Eugia aurobindo
Aside from Eugia's manufacturing shortfalls, its parent company, Aurobindo, received its own Form 483 wrist-slap in late December. Ultimately, the FDA classified the Aurobindo facility, located ...
- Safe
- United States
- Encrypted
- 17 yrs old
- 16,628 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Trends
Aurobindo posted Ebitda of Rs 4,387 crore and a net profit of Rs 2,647 crore in FY22. In May 2021, Aurobindo Pharma approved the transfer of its injectable assets into Eugia Pharma Specialities Ltd for "greater focus, attention, and...
- Safe
- United States
- Encrypted
- 28 yrs old
- 220 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around ₹4,500 crore. "With the markets in a buoyant phase and pharma valuations looking attractive, Aurobindo Pharma is now evaluating a listing of Eugia. The deal was...
- Safe
- India
- Encrypted
- 21 yrs old
- 8,206 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Since then, Eugia has agreed to sell the New Jersey plant. Separately, Aurobindo released a shareholder presentation (PDF) that reports almost half of its $2.9 billion in profits through its most ...
- Safe
- United States
- Encrypted
- 17 yrs old
- 16,628 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Aurobindo Pharma temporarily stops manufacturing at Eugia's Unit-III facility in Hyderabad after receiving 9 USFDA observations. The company is working to address the issues and resume ...
- Safe
- United States
- Encrypted
- 28 yrs old
- 220 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Eugia's parent parent Aurobindo Pharma was founded in 1986 by P.V. Ramprasad Reddy, K. Nityananda Reddy and a small group of professionals. According to the firm's website, in addition to being a ...
- Safe
- United States
- Encrypted
- 25 yrs old
- 783 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
USFDA Observations: In the intricate world of pharmaceuticals, maintaining the highest standards of manufacturing is paramount. A recent development has brought Aurobindo Pharma, a prominent player in the industry, into the spotlight. The Pashamylaram...
- Safe
- Encrypted
Aurobindo Pharma announced that it has entered into a share purchase agreement to acquire 100% equity share capital of MViyeS Pharma Ventures Private Limited (MViyeS). The acquisition was completed on November 6, 2020, the company said in its press...
- Safe
- India
- Encrypted
- 13 yrs old
- 323,496 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Aurobindo Pharma Ltd on Tuesday announced that its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator for its generic version of Vasopressin ...
- Safe
- United States
- Encrypted
- 26 yrs old
- 2,701 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Eugia adapts to changing norms in the market. Our offerings reflect our flexibility: Customized product procurement solutions for GPO partners. Fair pricing models for hospitals. The fulfillment of drop shipment agreements. Accessibility. Transparency....
- Safe
- Encrypted
{{domain}}
WEBSITE REPORT CARD
WEBSITE REPORT CARD
-
Norton safe Web
-
McAfee Web Advisor
-
Site is
-
Hosted in
-
-
Traffic rank:
-
Site age:
-
Site Owner information